CHONDROTISSUE BY BIOTISSUE
DEAD

Serial Number

77852766

Owner

BioTissue AG

Attorney

Patrick J. Jennings

Filing Date

Oct 20, 2009

Add to watchlist:

No watchlists yet
View on USPTO

CHONDROTISSUE BY BIOTISSUE Trademark

Serial Number: 77852766

CHONDROTISSUE BY BIOTISSUE is a trademark filed by BioTissue AG on October 20, 2009. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

BioTissue AG (3 trademarks)

Scheideggstraße 73

Entity Type: 99

Trademark Details

Filing Date

October 20, 2009

Registration Date

Not Registered

Goods & Services

Polymer-based pharmaceutical preparations for use in tissue and organ transplantation, namely, regenerative, reparative and hemostatic preparations, consisting of hyaluronic acid and bioresorbable polyglycolic acid polymers; biomedical polymer-based pharmaceutical preparations, namely, preparations for use in tissue and organ transplantation, namely regenerative, reparative and hemostatic preparations, consisting of hyaluronic acid and bioresorbable polyglycolic acid polymers

Medical devices in the nature of surgical implants primarily comprising artificial tissue, also consisting of biological cartilage, intervertebral disc, meniscus, tendon, ligament, bone and connective tissue substitutes intended for subsequent implantation, all sold as a unit; surgical implants primarily comprising artificial tissue, also consisting of hyaluronic acid, biological polymers, bioresorbable polymers and combinations thereof, all sold as a unit; biological surgical implants primarily comprising artificial tissue also consisting of hyaluronic acid, biological polymers, bioresorbable polymers and combinations thereof, all sold as a unit; health care products in the nature of surgical implants primarily comprising artificial tissue, also consisting of biological cartilage, intervertebral disc, meniscus, tendon, ligament, bone and connective tissue substitutes intended for subsequent implantation, all sold as a unit; products of tissue engineering, namely, surgical implants and modified surgical implants primarily comprising artificial material, also consisting of biological materials, all sold as a unit; tissue precursors, namely, surgical implants primarily comprising artificial material also consisting of molecules, namely, hyaluronic acid, biological polymers, bioresorbable polymers and combinations thereof produced in vitro for replacing and supporting the function of absent or injured body parts, all sold as a unit; artificial cartilage replacements and tissue replacements, namely, primarily artificial substitutes for bones, cartilage, ligaments, and tendons, also consisting of implants of hyaluronic acid, biological polymers, bioresorbable polymers and combinations thereof, all sold as a unit; biological replacement and biological protection of mesenchymal tissue, namely, primarily artificial substitutes for bones, cartilage, ligaments and tendons also consisting of implants of hyaluronic acid, biological polymers, bioresorbable polymers and combinations thereof, all sold as a unit

Research and development of pharmaceutical preparations and medicines; consultancy in the field of biomedicine

Filing History

ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Aug 30, 2010 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Aug 30, 2010 ABN2
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 18, 2010 TCCA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 1, 2010 GNRN
NON-FINAL ACTION E-MAILED
Feb 1, 2010 GNRT
NON-FINAL ACTION WRITTEN
Feb 1, 2010 CNRT
ASSIGNED TO EXAMINER
Jan 25, 2010 DOCK
TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Oct 26, 2009 TAEA
TEAS VOLUNTARY AMENDMENT RECEIVED
Oct 26, 2009 PARI
NOTICE OF PSEUDO MARK MAILED
Oct 24, 2009 MPMK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 23, 2009 NWOS
NEW APPLICATION ENTERED
Oct 23, 2009 NWAP